Armata Pharmaceuticals, Inc. — Director's Dealing 2022

Apr 1, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Armata Pharmaceuticals, Inc. (ARMP)
CIK: 0000921114
Period of Report: 2022-03-31

Reporting Person: Innoviva, Inc. (Director, 10% Owner)
Reporting Person: Innoviva Strategic Opportunities LLC (Director, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-03-31	Common Stock	P	5385208	$5.00	Acquired	16365969	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-03-31	Warrants to Purchase Common Stock	$5.00	P	0	Acquired	2027-03-31	Common Stock (2692604)	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	8710800	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Warrants to Purchase Common Stock	$5.00		Common Stock ()	1807396	Indirect
Warrants to Purchase Common Stock	$3.25		Common Stock ()	6153847	Indirect
Warrants to Purchase Common Stock	$2.87		Common Stock ()	8710800	Direct

Footnotes

F1: See Exhibit 99.1

F2: See Exhibit 99.1

F3: See Exhibit 99.1

F4: See Exhibit 99.1

F5: See Exhibit 99.1